advertisement

You do not have JavaScript enabled or are using an older version of Adobe Flash. You can update your version of Adobe Flash here.

UPDATE 1-Novartis Sees FDA Decision on Menveo Early 2010

ShareThis
Article Tools
  • Email a Colleague
  • Print
  • ShareThis

Source: Reuters

Thursday, July 02, 2009

Novartis (NOVN.VX)said it expects the U.S Food and Drug Administration to rule on the Swiss pharmaceuticals company's Menveo meningitis vaccine in early 2010 after the regulator sought more information about the treatment.


Full Story

Related Links

News Search

Search News By Keywords

News Sections

New Technologies

Human Serum Albumin, Lipid Enhanced for Microbial Culture Growth Promotion
Human Serum Albumin, Lipid Enhanced...
from NOVA Biologics, Inc.
More New Technologies
advertisement

You do not have JavaScript enabled or are using an older version of Adobe Flash. You can update your version of Adobe Flash here.

Email Newsletter Sign-Up

Stay updated on the latest technologies and news with Biocompare's newsletters
(See samples here)






 Select All

Privacy Policy | Manage Subscriptions

Loading

Loading